VC

Vivo Capital Portfolio holdings

AUM $977M
1-Year Return 209.68%
This Quarter Return
+36.8%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$706M
AUM Growth
+$239M
Cap. Flow
+$195M
Cap. Flow %
27.68%
Top 10 Hldgs %
75.21%
Holding
36
New
6
Increased
3
Reduced
5
Closed
2

Top Buys

1
VYNE icon
VYNE Therapeutics
VYNE
+$151M
2
ASND icon
Ascendis Pharma
ASND
+$26.2M
3
QTTB icon
Q32 Bio
QTTB
+$21.7M
4
ARWR icon
Arrowhead Research
ARWR
+$13.7M
5
CBAY
Cymabay Therapeutics
CBAY
+$10.4M

Top Sells

1
AAAP
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
+$20.3M
2
AIMT
Aimmune Therapeutics, Inc.
AIMT
+$10.7M
3
SBBP
Strongbridge Biopharma plc.
SBBP
+$4.73M
4
CRSP icon
CRISPR Therapeutics
CRSP
+$2.31M
5
KALA icon
KALA BIO
KALA
+$1.83M

Sector Composition

1 Healthcare 95.38%
2 Materials 2.68%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ZGNX
26
DELISTED
Zogenix, Inc.
ZGNX
$4.21M 0.6%
105,000
– –
AGRX
27
DELISTED
Agile Therapeutics, Inc
AGRX
$3.89M 0.55%
757
– –
TMBR
28
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$3.73M 0.53%
1,075
+155
+17% +$537K
MDGL icon
29
Madrigal Pharmaceuticals
MDGL
$9.63B
$3.18M 0.45%
+27,220
New +$3.18M
KALV icon
30
KalVista Pharmaceuticals
KALV
$708M
$2.85M 0.4%
300,325
– –
TRVN
31
DELISTED
Trevena, Inc.
TRVN
$2.83M 0.4%
2,765
– –
AKTX
32
Akari Therapeutics
AKTX
$25.7M
$629K 0.09%
17,293
– –
VIRX
33
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$532K 0.08%
5,585
-8,701
-61% -$829K
SLNOW
34
DELISTED
Soleno Therapeutics, Inc. Series A Warrant
SLNOW
$23K ﹤0.01%
188,772
– –
CRSP icon
35
CRISPR Therapeutics
CRSP
$5.12B
– –
-98,511
Closed -$2.31M
AAAP
36
DELISTED
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
– –
-249,241
Closed -$20.3M
1
2